Business Context and Reporting Period
Company: Trupanion, Inc. (TRUP)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2025
Business Overview: Trupanion provides medical insurance for cats and dogs in the U.S., Canada, and parts of Europe. The company operates two segments: a core "Subscription Business" (direct-to-consumer) and an "Other Business" segment (B2B underwriting, primarily for Pets Best).
Key Financial Metrics
| Metric (in thousands) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Total Revenue | $366,920 | $327,456 | $1,062,452 | $948,377 |
| Net Income (Loss) | $5,873 | $1,425 | $13,803 | $(11,289) |
| Operating Income (Loss) | $5,859 | $1,746 | $6,700 | $(9,862) |
| Diluted EPS | $0.13 | $0.03 | $0.32 | $(0.27) |
| Operating Cash Flow (9M) | $60,226 (2025) vs $24,585 (2024) | |||
| Cash & Short-term Investments | $348.5 million (as of Sept 30, 2025) | |||
| Long-term Debt | $113.8 million (as of Sept 30, 2025) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 12% year-over-year (YoY) for both the quarter and nine-month periods. Subscription business revenue grew 15% (Q3) and 16% (9M), driven by an 11% increase in monthly average revenue per pet and higher enrollment. Other business revenue grew 5% YoY, driven by higher per-pet revenue despite a decline in pet months due to the run-off of the Pets Best portfolio.
- Profitability: The company returned to profitability, reporting net income of $5.9 million for Q3 2025 compared to $1.4 million in Q3 2024. For the nine months ended Sept 30, 2025, net income was $13.8 million, a significant turnaround from a net loss of $11.3 million in the prior year period.
- Expense Trends:
- Veterinary Invoice Expense: Increased 14% in Q3 and 12% in 9M, reflecting higher claims frequency and veterinary inflation.
- Acquisition Costs: New pet acquisition expense rose 20% in Q3 and 18% in 9M as the company increased marketing spend to acquire new members. Average Pet Acquisition Cost (PAC) increased to $290 in Q3 2025 from $243 in Q3 2024.
- Technology & G&A: Technology expenses rose 25% in Q3 due to compensation increases and reduced capitalization of software. G&A expenses rose 8% in Q3 and 24% in 9M, primarily due to compensation and underwriting fees.
- Non-GAAP Metrics: Subscription business cost of paying veterinary invoices improved to 70.1% of revenue in Q3 2025 from 71.0% in Q3 2024.
Guidance, Outlook, and Risks
- Debt Refinancing (Subsequent Event): In November 2025, the company repaid its previous $150 million Credit Facility in full. It entered a new agreement with PNC Bank for a $120 million facility ($100 million term loan, $20 million revolver) maturing in November 2028. The new facility carries a floating interest rate (SOFR + 2.75%).
- Strategic Shifts: The company is transitioning Canadian underwriting from a fronting arrangement to its new subsidiary, GPIC Insurance Company. It also plans to assume full insurance risk for European products currently underwritten by third parties.
- Unusual Items: The nine-month 2025 results included a $7.8 million realized gain from a nonmonetary exchange where the company swapped its preferred stock investment in Baystride, Inc. for intellectual property.
- Risks:
- Indebtedness: The company notes that substantial indebtedness could limit flexibility and increase vulnerability to economic downturns.
- Interest Rate Volatility: The new PNC facility is tied to SOFR, exposing the company to interest rate fluctuations.
- Claims Development: The company experienced $2.8 million in unfavorable claims development in the subscription segment for the nine months ended Sept 30, 2025, driven by higher-than-expected claim frequency.
Investor Verification Checklist
- Debt Servicing: Verify the impact of the new PNC facility's floating interest rate on future interest expense given current rate environments.
- Claims Frequency: Monitor the "unfavorable development" in veterinary invoice reserves ($2.8M in 9M 2025) to assess if pricing adjustments are keeping pace with veterinary inflation.
- Acquisition Efficiency: Track the trend of Average Pet Acquisition Cost (PAC), which rose to $290 in Q3 2025, to ensure the increased spend yields a positive return on investment over the pet's lifetime.
- Segment Mix: Observe the continued run-off of the "Other Business" segment (Pets Best) and the growth rate of the core "Subscription Business" to confirm the strategic pivot is successful.
- Cash Position: Confirm the liquidity position of insurance subsidiaries ($290 million held by insurance entities) versus the parent company to understand capital deployment flexibility.